HEMABATE
PFIZER CANADA ULC
Quick answers
Is there a shortage of HEMABATE in Canada?
No. There is no current shortage of HEMABATE 250MCG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
CARBOPROST TROMETHAMINE INJECTION
JAMP PHARMA CORPORATION
CARBOPROST TROMETHAMINE INJECTION, USP
DR REDDY'S LABORATORIES LTD
CARBOPROST TROMETHAMINE INJECTION USP
JUNO PHARMA CANADA INC.
DIN
02230417
Strength
250MCG
Dosage Form
Solution
Route
Intramuscular
Active Ingredient
CARBOPROST (CARBOPROST TROMETHAMINE)
See all CARBOPROST (CARBOPROST TROMETHAMINE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347